Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
Covance is dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
Barriers to Recruitment in a Global cUTI Drug Study
Real-time evidence helped correct the course in a Phase II clinical study evaluating a treatment for complicated urinary tract infections (cUTIs).
Symposium at Rudding Park
Register for Intelligent Screening: Evolving Your Data Approaches & Drivers
Join us at the beautiful Rudding Park estate, just outside of Harrogate, UK, for an exclusive, intimate and free symposium, exploring DMPK and genetic toxicology screening data drivers and approaches on October 3-4, 2018. Reserve your seat today
Access the latest in scientific and patient centric solutions for your Rare Disease and Orphan Drug Development Program
Xcellerate® Informatics Suite
Successful clinical trials begin and end with the RIGHT data. Uncover new possibilities for your clinical trials with Xcellerate®, a fully integrated informatics platform. ONE comprehensive platform. UNPARALLELED RESULTS.
Trailblazer Webinar Series: Secrets for a Biotech Breakthrough
Gain valuable insights and advice from this four-part webinar series led by industry experts and entrepreneurs on how they made their biotech dreams come alive.
Providing Regulatory Support in China for a New Compound
Learn how Covance secured a priority and fast-track review to advance a unique combination antibiotic treatment.
Bioanalysis Education Center: Covance leads the way in bioanalytical capabilities and solutions, igniting innovation with exceptional science and timely answers.
Access the latest scientific posters, list of non-proprietary/generic assays, publications and info sheets.
Game Changer: Phase I cGMP Drug Manufacture at the CRU
Learn how one client avoided 6-9 month delays and achieved savings of 25 - 50% on drug manufacture costs versus CMO production
Immuno-oncology and the role of biomarkers, companion and complementary diagnostics
Learn more about how the use of a variety of biomarkers, companion diagnostics (CDx) and complementary diagnostics has powered the recent evolution of immunotherapies and their potential applications.
Covance leads the way in CMC analytical testing capabilities and solutions, helping you to identify, assess and demonstrate control over your biologic’s Critical Quality Attributes.
Access the latest scientific posters, blogs, info sheets and service profiles
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.
Learn how to efficiently analyze and manage your pharmacokinetic (PK) data
Gain insights in our latest blog.